We are live on ! Find out more
EEG

E.E. Geduld Portfolio holdings

AUM $178M
1-Year Est. Return 29.34%
This Fund
S&P 500
This Quarter Est. Return
+6.66%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$186M
AUM Growth
+$44.3M
Cap. Flow
+$55.2M
Cap. Flow %
29.71%
Top 10 Hldgs %
58.03%
Holding
319
New
65
Increased
26
Reduced
45
Closed
58

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$9.83M
2
BABA icon
Alibaba
BABA
+$2.05M
3
CLR
CONTINENTAL RESOURCES INC.
CLR
+$1.48M
4
PAGP icon
Plains GP Holdings
PAGP
+$934K
5
ESPR
Esperion Therapeutics
ESPR
+$918K

Top Sells

Rank Stock Value
1
QLYS icon
Qualys
QLYS
+$931K
2
RAX
Rackspace Hosting Inc
RAX
+$814K
3
RKUS
RUCKUS WIRELESS INC COM STK (DE)
RKUS
+$735K
4
DTO
DB Crude Oil Double Short Exchange Traded Notes due June 1, 2038
DTO
+$712K
5
AY
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
+$712K

Sector Composition

Rank Sector Weight
1 Miscellaneous 43.2%
2 Financials 30.88%
3 Healthcare 9.98%
4 Consumer Discretionary 5.04%
5 Energy 3.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ECTE
176
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
$34K 0.02%
25,000
– –
C.WS.A
177
DELISTED
Citigroup Inc
C.WS.A
$22K 0.01%
25,000
– –
CVM.WS
178
DELISTED
Cel-Sci Corp Series S
CVM.WS
$14K 0.01%
100,000
– –
CASI
179
DELISTED
CASI Pharmaceuticals
CASI
$13K 0.01%
1,000
-1,000
-50% -$15.7K
OGEN icon
180
Oragenics
OGEN
$2.4M
$9K ﹤0.01%
1
– –
DVOX
181
DELISTED
DYNAVOX INC CL A COM STK (DE)
DVOX
$8K ﹤0.01%
150,000
– –
GSK icon
182
CALL
GSK
GSK
$101B
$7K ﹤0.01%
8,000
– –
EMIS
183
DELISTED
EMISPHERE TECHNOLOGIES INC
EMIS
$7K ﹤0.01%
25,000
– –
IGC.WS
184
DELISTED
INDIA GLOBALIZATION CAPITAL, INC. WTS EXP 3/06/2017
IGC.WS
$2K ﹤0.01%
157,798
– –
C.WS.B
185
DELISTED
CITIGROUP INC WTS EXP (10/28/2018) (DE)
C.WS.B
$1K ﹤0.01%
50,000
– –
AMH icon
186
American Homes 4 Rent
AMH
$12B
– –
-25,000
Closed -$422K
ARCT icon
187
Arcturus Therapeutics
ARCT
$460M
– –
-1,429
Closed -$154K
AUDC icon
188
AudioCodes
AUDC
$247M
– –
-45,000
Closed -$216K
BGS icon
189
CALL
B&G Foods
BGS
$282M
– –
-50,000
Closed -$1.38M
BGS icon
190
B&G Foods
BGS
$282M
– –
-15,000
Closed -$413K
CROX icon
191
Crocs
CROX
$5.83B
– –
-10,000
Closed -$126K
EWW icon
192
iShares MSCI Mexico ETF
EWW
$1.79B
– –
-5,000
Closed -$344K
GPRO icon
193
PUT
GoPro
GPRO
$112M
– –
-15,000
Closed -$1.41M
HRTX icon
194
Heron Therapeutics
HRTX
$63M
– –
-10,000
Closed -$83K
LULU icon
195
lululemon athletica
LULU
$13.1B
– –
-10,000
Closed -$420K
MSFT icon
196
CALL
Microsoft
MSFT
$3.75T
– –
-50,000
Closed -$2.32M
PLCE icon
197
Children's Place
PLCE
$54.5M
– –
-10,000
Closed -$477K
PRSO icon
198
Peraso
PRSO
$9.83M
– –
-7
Closed -$133K
QLYS icon
199
Qualys
QLYS
$6.52B
– –
-35,000
Closed -$931K
SHOO icon
200
Steven Madden
SHOO
$3.27B
– –
-22,500
Closed -$483K
6 7
8
9 10

Similar funds

BC
Bocage Capital San Francisco, California $185M AUM 61.49% 1-Year Est. Return
PFM
PacWest Financial Management Phoenix, Arizona $169M AUM 8.84% 1-Year Est. Return
SRP
Saddle Road Partners Omaha, Nebraska $197M AUM 13.19% 1-Year Est. Return
CF
CenterStar Fund Chicago, Illinois $159M AUM 13.43% 1-Year Est. Return
SA
Steadfast Advisors New York $204M AUM 28.42% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
SIG
Stanford Investment Group Mountain View, California $205M AUM 7.44% 1-Year Est. Return
VWM
Vector Wealth Management Minneapolis, Minnesota $142M AUM 10.42% 1-Year Est. Return

E.E. Geduld's Q4 2014 Portfolio in Review

As of Q4 2014, E.E. Geduld held 319 positions worth $186M, up 31% from $142M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

E.E. Geduld deployed $55.2M of net new capital in Q4 2014, opening 65 new positions and adding to 26 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 25,000 shares worth $81K.

By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, up from 32% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was General Motors Company, an estimated $667K trimmed.

  • E.E. Geduld's largest Q4 2014 buy was Regeneron Pharmaceuticals: 25,000 shares worth $81K.
  • E.E. Geduld added most to Hess in Q4 2014, an estimated $792K increase.
  • E.E. Geduld's biggest Q4 2014 reduction was General Motors Company, cutting an estimated $667K.
  • E.E. Geduld fully exited Qualys in Q4 2014, selling an estimated $931K.
  • E.E. Geduld's ten largest holdings make up 58% of its $186M portfolio in Q4 2014.
  • E.E. Geduld opened 65 new positions and closed 58 in Q4 2014.
  • E.E. Geduld's portfolio value rose 31% quarter-over-quarter to $186M.

Based on E.E. Geduld's 13F filing for Q4 2014, filed 30 Jan 2015.